GSK plc (GSK): Did This Healthcare Stock Show a Strong Performance in Q1?
Yahoo Finance · 3 days ago
Pfizer
Search results
The homepage of the GSK USA website. June 26 2024 Statement: US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices updates recommendations on adult RSV vaccines ahead of the next season ; June 13 2024 Students nationwide take on the role of space scientists during GSK science in the summer™ in collaboration with the Franklin Institute
- 38.50Add to watchlist-0.14 (-0.36%)At close: Fri. Jun 28, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open38.68High39.03Low38.45
- Mkt Cap78.54BP/E (TTM)14.00Div & Yield1.50 & 3.91%
- Prev. Close38.6452 Wk. Low33.6752 Wk. High45.93
What analysts are sayingTop storiesRelated stocks
Our purpose. We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
At GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. Close Video. Explore US career opportunities .
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.. GSK is the tenth largest pharmaceutical ...
We deliver over 1.5 million doses of our vaccines every day; and 4 out of 10 infants born each. year receive at least one GSK vaccine. Our vaccines portfolio targets infectious diseases at every stage of life, helping to protect people from RSV, meningitis, shingles, flu, polio and many more.
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
At a glance. GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US.
Our portfolio of more than 20 marketed vaccines is one of the industry’s broadest. We deliver over 1.5 million doses of our vaccines every day; and 4 out of 10 infants born each year receive at least one GSK vaccine. Our vaccines portfolio targets infectious diseases at every stage of life, helping to protect people from RSV, meningitis ...
Vaccines. We are leading the way in developing a broad portfolio and innovative pipeline of vaccines to make an impact for society. We deliver over two million vaccine doses per day to people living in over 160 countries. The vaccines in our portfolio have been helping to protect people from serious disease for well over 100 years, with our ...
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. Our largest US-based operation, the Upper Providence R&D hub features 8 smart labs and more than 3,000 GSK people discovering and developing new medicines which will change lives. We also do Research & Development in Boston, Massachusetts ...
